http://News);

7th AMR Conference 2023

We are looking forward to the 7th AMR Conference, March 16-17, Basel, Switzerland, where our CEO, Lloyd Payne and founder Zemer Gitai will be attending.

Read More Arrow Logo

BioInfect 2023

ArrePath is looking forward to taking part in BioInfect 2023 on February 1, 2023

Read More Arrow Logo

ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board

ArrePath today announced that it has appointed two new members to its Scientific Advisory Board (SAB):  Connor Coley, PhD, Henri Slezynger (1957) Career Development Assistant Professor in Chemical Engineering at MIT, and Paul Hergenrother, PhD, Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry, and Professor of Chemistry at the University of Illinois Urbana-Champaign.

Read More Arrow Logo

MassBio Innovation Week 2022

ArrePath is presenting at MassBio Innovation Week, December 6, 2022

Read More Arrow Logo

CYTODATA SYMPOSIUM 2022

ArrePath will be attending the seventh annual CytoData meeting, hosted by the Allen Institute for Cell Science, which will take place October 17-20, 2022 in Seattle, Washington.

Read More Arrow Logo

World Anti-Microbial Resistance Congress 2022

ArrePath is attending the World Anti-Microbial Resistance Congress taking place on September 7-8, 2022, in National Harbor, MD.

Read More Arrow Logo

2022 Conference on Neural Information Processing Systems

Join ArrePath at 2022 NeurIPS, a premier conference on Machine Learning and AI. This event is taking place at the New Orleans Convention Center on Monday, November 28th – Friday, December 9th.

Read More Arrow Logo

ArrePath Appoints Michael Dudley, PharmD, Chairman, Board of Directors

ArrePath today announced the appointment of Michael Dudley, PharmD, as Chairman of the Company’s Board of Directors.

Read More Arrow Logo

ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance

ArrePath announced today that it has raised $20 million in seed financing to advance its proprietary, machine learning (ML)-based platform for the discovery of new classes of anti-infectives to overcome antimicrobial resistance (AMR).

Read More Arrow Logo

New Antibacterial Discovery and Development Conference GRC

ArrePath will be at the 2022 Gordon Research Conference on New Antibacterial Discovery and Development happening July 24 – 29, 2022.

Read More Arrow Logo